{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:29:53Z","timestamp":1786980593357,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T00:00:00Z","timestamp":1403222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10157-014-0991-0","type":"journal-article","created":{"date-parts":[[2014,6,19]],"date-time":"2014-06-19T05:35:38Z","timestamp":1403156138000},"page":"336-342","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fluvastatin inhibits the expression of fibronectin in human peritoneal mesothelial cells induced by high-glucose peritoneal dialysis solution via SGK1 pathway"],"prefix":"10.1007","volume":"19","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaguang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,20]]},"reference":[{"key":"991_CR1","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1046\/j.1523-1755.1998.00180.x","volume":"54","author":"SJ Davies","year":"1998","unstructured":"Davies SJ, Phillips L, Griffiths AM, et al. What really happens to people on long-term peritoneal dialysis? Kidney Int. 1998;54:2207\u201317.","journal-title":"Kidney Int"},{"key":"991_CR2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1523-1755.1999.00264.x","volume":"55","author":"RT Krediet","year":"1999","unstructured":"Krediet RT. The peritoneal membrane in chronic peritoneal dialysis. Kidney Int. 1999;55:341\u201356.","journal-title":"Kidney Int"},{"key":"991_CR3","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1681\/ASN.V1251046","volume":"12","author":"SJ Davies","year":"2001","unstructured":"Davies SJ, Phillips L, Naish PF, et al. Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol. 2001;12:1046\u201351.","journal-title":"J Am Soc Nephrol"},{"key":"991_CR4","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1111\/j.1523-1755.2004.66021.x","volume":"66","author":"SJ Davies","year":"2004","unstructured":"Davies SJ. Longitudinal relationship between solute transport and ultrafiltration capacity in peritoneal dialysis patients. Kidney Int. 2004;66:2437\u201345.","journal-title":"Kidney Int"},{"key":"991_CR5","doi-asserted-by":"crossref","first-page":"F433","DOI":"10.1152\/ajprenal.00313.2004","volume":"288","author":"MF Flessner","year":"2005","unstructured":"Flessner MF. The transport barrier in intraperitoneal therapy. Am J Physiol Renal Physiol. 2005;288:F433\u201342.","journal-title":"Am J Physiol Renal Physiol"},{"key":"991_CR6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"991_CR7","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1681\/ASN.V1482109","volume":"14","author":"ASD Vriese","year":"2003","unstructured":"Vriese ASD, Flyvbjerg A, Mortier S, et al. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol. 2003;14:2109\u201318.","journal-title":"J Am Soc Nephrol"},{"key":"991_CR8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.V132470","volume":"13","author":"JD Williams","year":"2002","unstructured":"Williams JD, Craig KJ, Topley N, et al. Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol. 2002;13:470\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"991_CR9","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1523-1755.2004.00747.x","volume":"66","author":"JD Wiliams","year":"2004","unstructured":"Wiliams JD, Topley N, Craig KJ, et al. The Euro-balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int. 2004;66:408\u201318.","journal-title":"Kidney Int"},{"key":"991_CR10","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/ndt\/gfh793","volume":"20","author":"G Del Peso","year":"2005","unstructured":"Del Peso G, Ferna\u00b4ndez-Reyes MJ, Hevia C, et al. Factors influencing peritoneal transport parameters during the first year on peritoneal dialysis: peritonitis is the main factor. Nephrol Dial Transplant. 2005;20:1201\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"991_CR11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000047826","volume":"12","author":"S Fillon","year":"2002","unstructured":"Fillon S, Klingel K, Warntges S, et al. Expression of the serine\/threonine kinase hSGK1 in chronic viral hepatitis. Cell Physiol Biochem. 2002;12:47\u201354.","journal-title":"Cell Physiol Biochem"},{"key":"991_CR12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000066794","volume":"25","author":"B Friedrich","year":"2002","unstructured":"Friedrich B, Warntges S, Klingel K, et al. Up-regulation of the human serum and glucocorticoid-dependent kinase 1 in glomerulonephritis. Kidney Blood Press Res. 2002;25:303\u20137.","journal-title":"Kidney Blood Press Res"},{"key":"991_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000063790","volume":"12","author":"S Wa\u00a8rntges","year":"2002","unstructured":"Wa\u00a8rntges S, Klingel K, Weigert C, et al. Excessive transcription of the human serum and glucocorticoid dependent kinase hSGK1 in lung fibrosis. Cell Physiol Biochem. 2002;12:135\u201342.","journal-title":"Cell Physiol Biochem"},{"key":"991_CR14","doi-asserted-by":"crossref","first-page":"8157","DOI":"10.1073\/pnas.97.14.8157","volume":"97","author":"F Lang","year":"2000","unstructured":"Lang F, Klingel K, Wagner CA, et al. Deranged transcriptional regulation of cell-volume-sensitive kinase hSGK in diabetic nephropathy. Proc Natl Acad Sci USA. 2000;97:8157\u201362.","journal-title":"Proc Natl Acad Sci USA"},{"key":"991_CR15","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000225379","volume":"32","author":"H Yamahara","year":"2009","unstructured":"Yamahara H, Kishimoto N, Nakata M, et al. Direct aldosterone action as a profibrotic factor via ROS-mediated SGK1 in peritoneal fibroblasts. Kidney Blood Press Res. 2009;32:185\u201393.","journal-title":"Kidney Blood Press Res"},{"key":"991_CR16","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1152\/ajprenal.00565.2007","volume":"294","author":"H Nishimura","year":"2008","unstructured":"Nishimura H, Ito Y, Mizuno M, et al. Mineralocorticoid receptor blockade ameliorates peritoneal fibrosis in new rat peritonitis model. Am J Physiol Renal Physiol. 2008;294:1084\u201393.","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"991_CR17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000221063","volume":"32","author":"A Okazaki","year":"2009","unstructured":"Okazaki A, Mori Y, Nakata M, et al. Peritoneal mesothelial cells as a target of local aldosterone action: upregulation of connective tissue growth factor expression via serum- and glucocorticoid- inducible protein kinase 1. Kidney Blood Press Res. 2009;32(3):151\u201360.","journal-title":"Kidney Blood Press Res"},{"issue":"38","key":"991_CR18","first-page":"2677","volume":"87","author":"ZM Li","year":"2007","unstructured":"Li ZM, Ma JF, Wang LN. Influence of atorvastatin on the expression of monocyte chemoattractant protein-1 in peritoneal mesothelial cells by high glucose. Zhonghua Yi Xue Za Zhi. 2007;87(38):2677\u201380.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"3","key":"991_CR19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3747\/pdi.2010.00164","volume":"31","author":"B Carri\u00f3n","year":"2011","unstructured":"Carri\u00f3n B, P\u00e9rez-Mart\u00ednez FC, Monteagudo S, et al. Atorvastatin reduces high glucose toxicity in rat peritoneal mesothelial cells. Perit Dial Int. 2011;31(3):325\u201331.","journal-title":"Perit Dial Int"},{"issue":"12","key":"991_CR20","doi-asserted-by":"crossref","first-page":"4090","DOI":"10.1093\/ndt\/gfr229","volume":"26","author":"JE Lee","year":"2011","unstructured":"Lee JE, Oh KH, Choi KH, et al. Statin therapy is associated with improved survival in incident peritoneal dialysis patients: propensity-matched comparison. Nephrol Dial Transplant. 2011;26(12):4090\u20134.","journal-title":"Nephrol Dial Transplant"},{"key":"991_CR21","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0016-5085(99)70011-9","volume":"116","author":"S Waldegger","year":"1999","unstructured":"Waldegger S, Klingel K, Barth P, et al. h-SGK serine-threonine protein kinase gene as transcriptional target of transforming growth factor beta in human intestine. Gastroenterology. 1999;116:1081\u20138.","journal-title":"Gastroenterology"},{"key":"991_CR22","doi-asserted-by":"crossref","first-page":"G998","DOI":"10.1152\/ajpgi.2000.279.5.G998","volume":"279","author":"K Klingel","year":"2000","unstructured":"Klingel K, Warntges S, Bock J, et al. Expression of cell volume-regulated kinase h-sgk in pancreatic tissue. Am J Physiol Gastrointest Liver Physiol. 2000;279:G998\u20131002.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"991_CR23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1365-201X.2005.01428.x","volume":"184","author":"C Bistrup","year":"2005","unstructured":"Bistrup C, Thiesson HC, Jensen BL, et al. Reduced activity of 11 beta-hydroxysteroid dehydrogenase type 2 is not responsible for sodium retention in nephrotic rats. Acta Physiol Scand. 2005;184:161\u20139.","journal-title":"Acta Physiol Scand"},{"key":"991_CR24","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/CIRCULATIONAHA.105.569129","volume":"112","author":"J Steffel","year":"2005","unstructured":"Steffel J, Latini RA, Akhmedov A, et al. Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. Circulation. 2005;112:2002\u201311.","journal-title":"Circulation"},{"key":"991_CR25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0008-6363(00)00146-2","volume":"47","author":"KK Koh","year":"2000","unstructured":"Koh KK. Effects of statins on vascular wall: vasomotor function, inflammation, and plaque stability. Cardiovasc Res. 2000;47:648\u201357.","journal-title":"Cardiovasc Res"},{"key":"991_CR26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/0264-6021:3510095","volume":"351","author":"SP Davies","year":"2000","unstructured":"Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;351:95\u2013105.","journal-title":"Biochem J"},{"key":"991_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1365-2443.2001.00418.x","volume":"6","author":"H Mizuno","year":"2001","unstructured":"Mizuno H, Nishida E. The ERK MAP kinase pathway mediates induction of SGK (serum- and glucocorticoid-inducible kinase) by growth factors. Genes Cells. 2001;6:261\u20138.","journal-title":"Genes Cells"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-014-0991-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-014-0991-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-014-0991-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T17:02:34Z","timestamp":1649437354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-014-0991-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,20]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["991"],"URL":"https:\/\/doi.org\/10.1007\/s10157-014-0991-0","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,20]]}}}